These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 17000091

  • 1. Effects of paclitaxel, docetaxel and their combinations on subcutaneous lymphomas in inbred Sprague-Dawley/Cub rats.
    Otová B, Václavíková R, Danielová V, Holubová J, Ehrlichová M, Horský S, Soucek P, Simek P, Gut I.
    Eur J Pharm Sci; 2006 Dec; 29(5):442-50. PubMed ID: 17000091
    [Abstract] [Full Text] [Related]

  • 2. Antitumour activity of a combined treatment with PMEDAP and docetaxel in the Prague inbred Sprague-Dawley/cub rat strain bearing T-cell lymphoma.
    Bobkov K, Gut I, Mandys V, Holý A, Votruba I, Otová B.
    Anticancer Res; 2001 Dec; 21(4A):2725-31. PubMed ID: 11724347
    [Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin-induced diabetic rats.
    Lee JH, Lee A, Oh JH, Lee YJ.
    Biopharm Drug Dispos; 2012 Nov; 33(8):474-86. PubMed ID: 22936118
    [Abstract] [Full Text] [Related]

  • 4. Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models.
    Sampath D, Greenberger LM, Beyer C, Hari M, Liu H, Baxter M, Yang S, Rios C, Discafani C.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3459-69. PubMed ID: 16740771
    [Abstract] [Full Text] [Related]

  • 5. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.
    Choi YH, Suh JH, Lee JH, Cho IH, Lee MG.
    J Pharm Pharmacol; 2010 Aug 01; 62(8):1084-8. PubMed ID: 20663044
    [Abstract] [Full Text] [Related]

  • 6. Effects of cysteine on the pharmacokinetics of paclitaxel in rats.
    Lee YK, Han SY, Chin YW, Choi YH.
    Arch Pharm Res; 2012 Mar 01; 35(3):509-16. PubMed ID: 22477198
    [Abstract] [Full Text] [Related]

  • 7. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb 01; 14(75):16-8. PubMed ID: 15751170
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T, Wartmann M, Brueggen J, Allegrini PR, Floersheimer A, Maira M, McSheehy PM.
    Cancer Chemother Pharmacol; 2008 Nov 01; 62(6):1045-54. PubMed ID: 18301895
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of experimental hyperlipidaemia on the pharmacokinetics of docetaxel in rats.
    Lee JH, Oh JH, Lee YJ.
    Xenobiotica; 2011 Sep 01; 41(9):797-804. PubMed ID: 21561320
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
    Thomas SM, Ogagan MJ, Freilino ML, Strychor S, Walsh DR, Gooding WE, Grandis JR, Zamboni WC.
    Mol Pharmacol; 2008 Mar 01; 73(3):627-38. PubMed ID: 18025070
    [Abstract] [Full Text] [Related]

  • 15. Surfactants influence the distribution of taxanes in peritoneal dissemination tumor-bearing rats.
    Kamijo Y, Ito C, Nomura M, Sai Y, Miyamoto K.
    Cancer Lett; 2010 Jan 28; 287(2):182-6. PubMed ID: 19608331
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Taxanes: old drugs, new oral formulations.
    Jibodh RA, Lagas JS, Nuijen B, Beijnen JH, Schellens JH.
    Eur J Pharmacol; 2013 Oct 05; 717(1-3):40-6. PubMed ID: 23660368
    [Abstract] [Full Text] [Related]

  • 18. Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans.
    van Zuylen L, Verweij J, Nooter K, Brouwer E, Stoter G, Sparreboom A.
    Clin Cancer Res; 2000 Jul 05; 6(7):2598-603. PubMed ID: 10914699
    [Abstract] [Full Text] [Related]

  • 19. Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin.
    Jones B, Komarnitsky P, Miller GT, Amedio J, Wallner BP.
    Anticancer Drugs; 2012 Feb 05; 23(2):173-84. PubMed ID: 22027537
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.